Haijun Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haijun Xiao has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Feng Xue
B Department of Orthopedics , Shanghai Fenxian District Central Hospital , Shanghai , China
6 shared publicationsWeizhe Shi
B Department of Orthopedics , Shanghai Fenxian District Central Hospital , Shanghai , China
6 shared publicationsDu Yu
B Department of Orthopedics , Shanghai Fenxian District Central Hospital , Shanghai , China
4 shared publicationsJinyong Ju
A Department of Orthopedics , Ji'ning NO.1 People's Hospital , Shandong , China
4 shared publicationsMingmang Pan
Department of orthopedics, Shanghai Fengxian District Central Hospital, Shanghai, 201499, China
4 shared publicationsGuo Tang
B Department of Orthopedics , Shanghai Fenxian District Central Hospital , Shanghai , China
3 shared publications
Latest Publications
- 1 July 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (3)
Temporary Cement Prosthesis as a Bridge After Control of Axillary Artery Hemorrhage in Proximal Humeral Fracture-Dislocation
Case: A 64-year-old woman underwent open reduction and internal fixation for four-part proximal humeral fracture-dislocation with palpable distal pulses. Upon dislocated head removal, life-threatening hemorrhage occurred from posterior circumflex humeral artery tear. Bleeding was controlled through packing, resuscitation, and open vascular repair. Owing to unavailable shoulder prosthesis and prolonged operative time, a temporary cement prosthesis with Steinmann pins was used. At the 3-year follow-up, partial function was restored with no loosening. Conclusion: This case highlights axillary branch injury masked by tamponade effect. When arthroplasty unavailable, temporary cement prosthesis serves as a creative salvage option—a novel emergency application.
- 1 July 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (3)
Temporary Cement Prosthesis as a Bridge After Control of Axillary Artery Hemorrhage in Proximal Humeral Fracture-Dislocation
Case: A 64-year-old woman underwent open reduction and internal fixation for four-part proximal humeral fracture-dislocation with palpable distal pulses. Upon dislocated head removal, life-threatening hemorrhage occurred from posterior circumflex humeral artery tear. Bleeding was controlled through packing, resuscitation, and open vascular repair. Owing to unavailable shoulder prosthesis and prolonged operative time, a temporary cement prosthesis with Steinmann pins was used. At the 3-year follow-up, partial function was restored with no loosening. Conclusion: This case highlights axillary branch injury masked by tamponade effect. When arthroplasty unavailable, temporary cement prosthesis serves as a creative salvage option—a novel emergency application.
- Open Access
- 4 July 2025
- Published by Springer Nature in Biology Direct
- Vol. 20 (1) , 1-22
Unraveling the oxidative stress landscape in diabetic foot ulcers: insights from bulk RNA and single-cell RNA sequencing data
Oxidative stress plays a crucial role in the development of diabetic foot ulcers (DFU). However, its underlying mechanisms are not fully understood. The purpose of this study was to use bioinformatics and preliminary validation methods to preliminarily reveal the oxidative stress landscape in DFU. Based on the single-cell and bulk RNA sequencing data of DFU, we conducted differential genes screening, machine learning, PPI network construction, immune infiltration analysis, drug prediction, TF-mRNA-miRNA network, cell-cell interaction, pseudotime trajectory analysis, external cohort validation, and in vitro experiments to develop the oxidative stress landscape in DFU. Bulk RNA-seq analysis identified 63 oxidative stress-related genes of DFU (DORGs), and the top 59 genes were screened out for key nodes with close functional associations. Functional enrichment analysis showed significant involvement in oxidative stress response. Drug prediction highlighted Thymoquinone and Erlotinib as potential therapeutic candidates. Machine learning algorithms (SVM-RFE, LASSO and RF) identified BCL2 and 和FOXP2 as candidate hub DORGs for DFU diagnosis. Immune cell infiltration analysis indicated a significant presence of naive B cells and CD8 T cells in DFU. The analysis of single-cell RNA sequencing identified a total of 31,787 cells across 10 distinct clusters, with a notably lower proportion of fibroblasts in DFU group than that in the control group. The expression patterns of BCL2 and 和FOXP2 across the different groups were consistent with findings from bulk RNA sequencing analysis. Notably, fibroblasts derived from DFU patients exhibited the highest oxidative stress scores. Intercellular signaling analysis indicated that fibroblasts serve as crucial communication cells, primarily engaged in COLLAGEN signaling network. Additionally, fibroblasts are categorized into five distinct clusters. Among these, COL6A5+ fibroblasts constitute the predominant cluster in DFU and exhibit low differentiation potential. Furthermore, in vitro experiments successfully established a DFU oxidative stress model of fibroblasts, revealing reduced migration ability in the absence of cell death. Both in vitro findings and external data corroborated the decreased expression levels of BCL2and和FOXP2in DFU. The oxidative stress-related genes BCL2 and FOXP2 could serve as diagnostic markers for DFU. Furthermore, we identified the novel pathogenic mechanism associated with oxidative stress in DFU fibroblasts. This study may offer new insights for the diagnosis and treatment of DFU.
- 4 July 2025
- Published by Springer Nature in Biology Direct
- Vol. 20 (1) , 1-22
Open AccessUnraveling the oxidative stress landscape in diabetic foot ulcers: insights from bulk RNA and single-cell RNA sequencing data
Oxidative stress plays a crucial role in the development of diabetic foot ulcers (DFU). However, its underlying mechanisms are not fully understood. The purpose of this study was to use bioinformatics and preliminary validation methods to preliminarily reveal the oxidative stress landscape in DFU. Based on the single-cell and bulk RNA sequencing data of DFU, we conducted differential genes screening, machine learning, PPI network construction, immune infiltration analysis, drug prediction, TF-mRNA-miRNA network, cell-cell interaction, pseudotime trajectory analysis, external cohort validation, and in vitro experiments to develop the oxidative stress landscape in DFU. Bulk RNA-seq analysis identified 63 oxidative stress-related genes of DFU (DORGs), and the top 59 genes were screened out for key nodes with close functional associations. Functional enrichment analysis showed significant involvement in oxidative stress response. Drug prediction highlighted Thymoquinone and Erlotinib as potential therapeutic candidates. Machine learning algorithms (SVM-RFE, LASSO and RF) identified BCL2 and 和FOXP2 as candidate hub DORGs for DFU diagnosis. Immune cell infiltration analysis indicated a significant presence of naive B cells and CD8 T cells in DFU. The analysis of single-cell RNA sequencing identified a total of 31,787 cells across 10 distinct clusters, with a notably lower proportion of fibroblasts in DFU group than that in the control group. The expression patterns of BCL2 and 和FOXP2 across the different groups were consistent with findings from bulk RNA sequencing analysis. Notably, fibroblasts derived from DFU patients exhibited the highest oxidative stress scores. Intercellular signaling analysis indicated that fibroblasts serve as crucial communication cells, primarily engaged in COLLAGEN signaling network. Additionally, fibroblasts are categorized into five distinct clusters. Among these, COL6A5+ fibroblasts constitute the predominant cluster in DFU and exhibit low differentiation potential. Furthermore, in vitro experiments successfully established a DFU oxidative stress model of fibroblasts, revealing reduced migration ability in the absence of cell death. Both in vitro findings and external data corroborated the decreased expression levels of BCL2and和FOXP2in DFU. The oxidative stress-related genes BCL2 and FOXP2 could serve as diagnostic markers for DFU. Furthermore, we identified the novel pathogenic mechanism associated with oxidative stress in DFU fibroblasts. This study may offer new insights for the diagnosis and treatment of DFU.
- 9 September 2022
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 219, 112835
Hydrophilic competent and enhanced wet-bond strength castor oil-based bioadhesive for bone repair
- 9 September 2022
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 219, 112835
Hydrophilic competent and enhanced wet-bond strength castor oil-based bioadhesive for bone repair
- Open Access
- 16 June 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 892593
Identification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis
Background: Alterations of epigenetic modification patterns are potential markers of cancer. The current study characterized six histone modifications in osteosarcoma and identified epigenetically dysregulated long non-coding RNAs (epi-lncRNAs). Methods: Multi-omics data were obtained from osteosarcoma cell line SJSA1 and a normal cell line. Differentially expressed lncRNAs (DElncRNAs) between osteosarcoma and normal skeletal muscle were analyzed using Limma. MACS2 was applied to identify the “peaks” modified by each histone in the cell. Promoters or enhancers of DElncRNA were overlapped with differential histone-modified regions (DHMR) to screen epi-lncRNAs. Univariate and multivariate Cox regression analysis were performed to detect the genes closely related to the prognosis of osteosarcoma and to construct risk models. Results: A total of 17 symbolic epi-lncRNA in osteosarcoma were screened, and 13 of them were differentially expressed between osteosarcoma and normal samples. Eight epi-lncRNAs were retained by Univariate Cox regression analysis. Four of these epi-lncRNAs were used to construct an epi-lncRNA signature. The risk score of each osteosarcoma sample in the high- or low-risk group was estimated according to the epi-lncRNA signature. The overall survival (OS) of the low-risk group was significantly better than that of the high-risk group. The area under the receiver operating characteristic (ROC) curve of the model was 0.79 and 0.82 for 1-, 3-, and 5-year OS, respectively. Conclusion: Our results revealed the histone modification pattern in osteosarcoma and developed 4-epi-lncRNA signature to predict the prognosis of osteosarcoma, laying a foundation for the identification of highly specific epigenetic biomarkers for osteosarcoma.
- 16 June 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 892593
Open AccessIdentification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis
Background: Alterations of epigenetic modification patterns are potential markers of cancer. The current study characterized six histone modifications in osteosarcoma and identified epigenetically dysregulated long non-coding RNAs (epi-lncRNAs). Methods: Multi-omics data were obtained from osteosarcoma cell line SJSA1 and a normal cell line. Differentially expressed lncRNAs (DElncRNAs) between osteosarcoma and normal skeletal muscle were analyzed using Limma. MACS2 was applied to identify the “peaks” modified by each histone in the cell. Promoters or enhancers of DElncRNA were overlapped with differential histone-modified regions (DHMR) to screen epi-lncRNAs. Univariate and multivariate Cox regression analysis were performed to detect the genes closely related to the prognosis of osteosarcoma and to construct risk models. Results: A total of 17 symbolic epi-lncRNA in osteosarcoma were screened, and 13 of them were differentially expressed between osteosarcoma and normal samples. Eight epi-lncRNAs were retained by Univariate Cox regression analysis. Four of these epi-lncRNAs were used to construct an epi-lncRNA signature. The risk score of each osteosarcoma sample in the high- or low-risk group was estimated according to the epi-lncRNA signature. The overall survival (OS) of the low-risk group was significantly better than that of the high-risk group. The area under the receiver operating characteristic (ROC) curve of the model was 0.79 and 0.82 for 1-, 3-, and 5-year OS, respectively. Conclusion: Our results revealed the histone modification pattern in osteosarcoma and developed 4-epi-lncRNA signature to predict the prognosis of osteosarcoma, laying a foundation for the identification of highly specific epigenetic biomarkers for osteosarcoma.
- 17 May 2022
- Published by Elsevier in Tissue and Cell
- Vol. 76, 101807
MMP2 promotes osteoblast differentiation and calcification of muscle-derived mesenchymal stem cells by interaction with miR-29b-3p
- 17 May 2022
- Published by Elsevier in Tissue and Cell
- Vol. 76, 101807
MMP2 promotes osteoblast differentiation and calcification of muscle-derived mesenchymal stem cells by interaction with miR-29b-3p
- Open Access
- 13 May 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 897392
A Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification
Heterotopic ossification (HO) occurs when bone forms within non-ossifying tissues, such as in muscle. Palovarotene, an activator of retinoic acid receptor γ (RAR-γ), has been shown to inhibit the formation of ectopic bone in HO model mice, but its specific mechanism of action remains unclear. This study will explore the target and molecular mechanism of Palovarotene's action on HO by network pharmacology study. We collected the relevant targets of Palovarotene and HO from the database, obtained the potential targets of Palovarotene acting on HO through Venn analysis, and constructed the protein-protein interaction (PPI) network. Then, Gene Ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment Analysis and Module-based Network Analysis were performed for potential targets, and in addition, PPI Network Topology Analysis and Gene-Phenotype Correlation Analysis were performed. The results suggested that MAPK1, MDM2, and other targets as well as P53 signaling pathway and PI3K–Akt signaling pathway may be closely related to Palovarotene treatment of HO. We carried out verification experiments to confirm our finding, alkaline phosphatase and alizarin red staining in vitro and Micro-CT as well as hematoxylin-eosin staining in vivo were performed to verify treatment for HO of Palovarotene, reverse transcription polymerase chain reaction was also used to explore the transcription changes of MAPK1, MDM2, and osteogenic genes. This study systematically elucidated the possible mechanism of Palovarotene in the treatment of HO through network pharmacology study, revealing a new direction for the further application of Palovarotene in the treatment of HO.
- 13 May 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 897392
Open AccessA Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification
Heterotopic ossification (HO) occurs when bone forms within non-ossifying tissues, such as in muscle. Palovarotene, an activator of retinoic acid receptor γ (RAR-γ), has been shown to inhibit the formation of ectopic bone in HO model mice, but its specific mechanism of action remains unclear. This study will explore the target and molecular mechanism of Palovarotene's action on HO by network pharmacology study. We collected the relevant targets of Palovarotene and HO from the database, obtained the potential targets of Palovarotene acting on HO through Venn analysis, and constructed the protein-protein interaction (PPI) network. Then, Gene Ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment Analysis and Module-based Network Analysis were performed for potential targets, and in addition, PPI Network Topology Analysis and Gene-Phenotype Correlation Analysis were performed. The results suggested that MAPK1, MDM2, and other targets as well as P53 signaling pathway and PI3K–Akt signaling pathway may be closely related to Palovarotene treatment of HO. We carried out verification experiments to confirm our finding, alkaline phosphatase and alizarin red staining in vitro and Micro-CT as well as hematoxylin-eosin staining in vivo were performed to verify treatment for HO of Palovarotene, reverse transcription polymerase chain reaction was also used to explore the transcription changes of MAPK1, MDM2, and osteogenic genes. This study systematically elucidated the possible mechanism of Palovarotene in the treatment of HO through network pharmacology study, revealing a new direction for the further application of Palovarotene in the treatment of HO.
- Open Access
- 5 May 2022
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-30
Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing’s Sarcoma Using Bioinformatics Analysis
This study was aimed at exploring common oncogenic genes and pathways both in osteosarcoma and Ewing’s sarcoma. Microarray data were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using the limma package. Then, protein-protein interaction (PPI) networks were constructed and hub genes were identified. Furthermore, functional enrichment analysis was analyzed. The expression of common oncogenic genes was validated in 38 osteosarcoma and 17 Ewing’s sarcoma tissues by RT-qPCR and western blot compared to normal tissues. 201 genes were differentially expressed. There were 121 nodes and 232 edges of the PPI network. Among 12 hub genes, hub genes FN1, COL1A1, and COL1A2 may involve in the development of osteosarcoma and Ewing’s sarcoma. And they were reduced to expression both in osteosarcoma and Ewing’s sarcoma tissues at mRNA and protein levels compared to normal tissues. Knockdown of FN1, COL1A1, and COL1A2 enhanced the cell proliferation and migration of U2OS under the restriction of cisplatin. Our findings revealed the common oncogenic genes such as FN1, COL1A1, and COL1A2, which may act as antioncogene by enhancing cisplatin sensitivity in osteosarcoma cells, and pathways were both in osteosarcoma and Ewing’s sarcoma.
- 5 May 2022
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-30
Open AccessIdentification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing’s Sarcoma Using Bioinformatics Analysis
This study was aimed at exploring common oncogenic genes and pathways both in osteosarcoma and Ewing’s sarcoma. Microarray data were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using the limma package. Then, protein-protein interaction (PPI) networks were constructed and hub genes were identified. Furthermore, functional enrichment analysis was analyzed. The expression of common oncogenic genes was validated in 38 osteosarcoma and 17 Ewing’s sarcoma tissues by RT-qPCR and western blot compared to normal tissues. 201 genes were differentially expressed. There were 121 nodes and 232 edges of the PPI network. Among 12 hub genes, hub genes FN1, COL1A1, and COL1A2 may involve in the development of osteosarcoma and Ewing’s sarcoma. And they were reduced to expression both in osteosarcoma and Ewing’s sarcoma tissues at mRNA and protein levels compared to normal tissues. Knockdown of FN1, COL1A1, and COL1A2 enhanced the cell proliferation and migration of U2OS under the restriction of cisplatin. Our findings revealed the common oncogenic genes such as FN1, COL1A1, and COL1A2, which may act as antioncogene by enhancing cisplatin sensitivity in osteosarcoma cells, and pathways were both in osteosarcoma and Ewing’s sarcoma.
- Open Access
- 28 April 2022
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-15
Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-κB Signaling Pathway following Stimulation of the Inflammatory Microenvironment
Heterotopic ossification (HO) is defined as the formation of bone tissues outside the bones, such as in the muscles. Currently, the mechanism of HO is still unclear. Tendon stem cells (TSCs) play important roles in the occurrence and development of HO. The inflammatory microenvironment dominated by macrophages also plays an important role in the course of HO. The commonly used clinical treatment methods, such as nonsteroidal anti-inflammatory drugs and radiotherapy, have relatively large side effects, and more efficient treatment methods are needed in clinical practice. Under physiological conditions, retinoic acid receptor (RAR) signal transduction pathway inhibits osteogenic progenitor cell aggregation and chondrocyte differentiation. We focus on palovarotene, a retinoic acid γ-receptor activator, showing an inhibitory effect on HO mice, but the specific mechanism is still unclear. This study was aimed at exploring the specific molecular mechanism of palovarotene by blocking osteogenic differentiation and HO formation of TSCs in vitro and in vivo in an inflammatory microenvironment. We constructed a coculture model of TCSs and polarized macrophages, as well as overexpression and knockdown models of the Smad signaling pathway of TCSs. In addition, a rat model of HO, which was constructed by Achilles tendon resection, was also established. These models explored the role of inflammatory microenvironment and Smad signaling pathways in the osteogenic differentiation of TSCs which lead to HO, as well as the reversal role played by palovarotene in this process. Our results suggest that, under the stimulation of inflammatory microenvironment and trauma, the injured site was in an inflammatory state, and macrophages were highly concentrated in the injured site. The expression of osteogenic and inflammation-related proteins, as well as Smad proteins, was upregulated. Osteogenic differentiation was performed in TCSs. We also found that TCSs activated Smad and NF-κB signaling pathways, which initiated the formation of HO. Palovarotene inhibited the aggregation of osteogenic progenitor cells and macrophages and attenuated HO by blocking Smad and NF-κB signaling pathways. Therefore, palovarotene may be a novel HO inhibitor, while other drugs or antibodies targeting Smad and NF-κB signaling pathways may also prevent or treat HO. The expressions of Smad5, Id1, P65, and other proteins may predict HO formation.
- 28 April 2022
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-15
Open AccessPalovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-κB Signaling Pathway following Stimulation of the Inflammatory Microenvironment
Heterotopic ossification (HO) is defined as the formation of bone tissues outside the bones, such as in the muscles. Currently, the mechanism of HO is still unclear. Tendon stem cells (TSCs) play important roles in the occurrence and development of HO. The inflammatory microenvironment dominated by macrophages also plays an important role in the course of HO. The commonly used clinical treatment methods, such as nonsteroidal anti-inflammatory drugs and radiotherapy, have relatively large side effects, and more efficient treatment methods are needed in clinical practice. Under physiological conditions, retinoic acid receptor (RAR) signal transduction pathway inhibits osteogenic progenitor cell aggregation and chondrocyte differentiation. We focus on palovarotene, a retinoic acid γ-receptor activator, showing an inhibitory effect on HO mice, but the specific mechanism is still unclear. This study was aimed at exploring the specific molecular mechanism of palovarotene by blocking osteogenic differentiation and HO formation of TSCs in vitro and in vivo in an inflammatory microenvironment. We constructed a coculture model of TCSs and polarized macrophages, as well as overexpression and knockdown models of the Smad signaling pathway of TCSs. In addition, a rat model of HO, which was constructed by Achilles tendon resection, was also established. These models explored the role of inflammatory microenvironment and Smad signaling pathways in the osteogenic differentiation of TSCs which lead to HO, as well as the reversal role played by palovarotene in this process. Our results suggest that, under the stimulation of inflammatory microenvironment and trauma, the injured site was in an inflammatory state, and macrophages were highly concentrated in the injured site. The expression of osteogenic and inflammation-related proteins, as well as Smad proteins, was upregulated. Osteogenic differentiation was performed in TCSs. We also found that TCSs activated Smad and NF-κB signaling pathways, which initiated the formation of HO. Palovarotene inhibited the aggregation of osteogenic progenitor cells and macrophages and attenuated HO by blocking Smad and NF-κB signaling pathways. Therefore, palovarotene may be a novel HO inhibitor, while other drugs or antibodies targeting Smad and NF-κB signaling pathways may also prevent or treat HO. The expressions of Smad5, Id1, P65, and other proteins may predict HO formation.
- Open Access
Effects of Polydopamine Microspheres Loaded with Silver Nanoparticles on Lolium multiflorum: Bigger Size, Less Toxic
The rapid development of nanotechnology and its widespread use have given rise to serious concerns over the potential adverse impacts of nanomaterials on the Earth’s ecosystems. Among all the nanomaterials, silver nanoparticles (AgNPs) are one of the most extensively used nanomaterials due to their excellent antibacterial property. However, the toxic mechanism of AgNPs in nature is still unclear. One of the questions under debate is whether the toxicity is associated with the size of AgNPs or the silver ions released from AgNPs. In our previous study, a sub-micron hybrid sphere system with polydopamine-stabilized AgNPs (Ag@PDS) was synthesized through a facile and green method, exhibiting superior antibacterial properties. The current study aims to explore the unique toxicity profile of this hybrid sphere system by studying its effect on germination and early growth of Lolium multiflorum, with AgNO3 and 15 nm AgNPs as a comparison. The results showed the seed germination was insensitive/less sensitive to all three reagents; however, vegetative growth was more sensitive. Specifically, when the Ag concentration was lower than 40 mg/L, Ag@PDS almost had no adverse effects on the root and shoot growth of Lolium multiflorum seeds. By contrast, when treated with AgNO3 at a lower Ag concentration of 5 mg/L, the plant growth was inhibited significantly, and was reduced more in the case of AgNP treatment at the same Ag concentration. As the exposures of Ag@PDS, AgNO3, and AgNPs increased, so did the Ag content in the root and shoot. In general, Ag@PDS was proven to be a potential useful hybrid material that retains antibacterial property with light phytotoxicity.
Open AccessEffects of Polydopamine Microspheres Loaded with Silver Nanoparticles on Lolium multiflorum: Bigger Size, Less Toxic
The rapid development of nanotechnology and its widespread use have given rise to serious concerns over the potential adverse impacts of nanomaterials on the Earth’s ecosystems. Among all the nanomaterials, silver nanoparticles (AgNPs) are one of the most extensively used nanomaterials due to their excellent antibacterial property. However, the toxic mechanism of AgNPs in nature is still unclear. One of the questions under debate is whether the toxicity is associated with the size of AgNPs or the silver ions released from AgNPs. In our previous study, a sub-micron hybrid sphere system with polydopamine-stabilized AgNPs (Ag@PDS) was synthesized through a facile and green method, exhibiting superior antibacterial properties. The current study aims to explore the unique toxicity profile of this hybrid sphere system by studying its effect on germination and early growth of Lolium multiflorum, with AgNO3 and 15 nm AgNPs as a comparison. The results showed the seed germination was insensitive/less sensitive to all three reagents; however, vegetative growth was more sensitive. Specifically, when the Ag concentration was lower than 40 mg/L, Ag@PDS almost had no adverse effects on the root and shoot growth of Lolium multiflorum seeds. By contrast, when treated with AgNO3 at a lower Ag concentration of 5 mg/L, the plant growth was inhibited significantly, and was reduced more in the case of AgNP treatment at the same Ag concentration. As the exposures of Ag@PDS, AgNO3, and AgNPs increased, so did the Ag content in the root and shoot. In general, Ag@PDS was proven to be a potential useful hybrid material that retains antibacterial property with light phytotoxicity.
- 20 May 2021
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 9 (21) , 7228-7236
RBC-derived nanosystem with enhanced ferroptosis triggered by oxygen-boosted phototherapy for synergized tumor treatment
Photodynamic and ferroptosis therapies for cancer treatment are restricted by the scarcity of oxygen and Fe in cancer cells, and the complicated structure of delivery systems. Herein, a red blood cell-derived vehicle (RDV) inherently enriched with hemoglobin co-delivers a photosensitizer, Ce6, and a ferroptosis promoter, sorafenib (SRF) into cancer cells for boosting oxygen and providing iron, which leads to enhanced PDT and stronger ferroptosis therapy. Damage to the RDV membrane under local irradation leads to SRF release at the tumor site for tumor-targeted therapy. The lipid membrane of the RDV could also improve the drug delivery efficiency in vitro and in vivo. The novel nanosystem exhibited enhanced tumor killing efficacy and improved safety compared with traditional PDT and ferroptosis therapy.
- 20 May 2021
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 9 (21) , 7228-7236
RBC-derived nanosystem with enhanced ferroptosis triggered by oxygen-boosted phototherapy for synergized tumor treatment
Photodynamic and ferroptosis therapies for cancer treatment are restricted by the scarcity of oxygen and Fe in cancer cells, and the complicated structure of delivery systems. Herein, a red blood cell-derived vehicle (RDV) inherently enriched with hemoglobin co-delivers a photosensitizer, Ce6, and a ferroptosis promoter, sorafenib (SRF) into cancer cells for boosting oxygen and providing iron, which leads to enhanced PDT and stronger ferroptosis therapy. Damage to the RDV membrane under local irradation leads to SRF release at the tumor site for tumor-targeted therapy. The lipid membrane of the RDV could also improve the drug delivery efficiency in vitro and in vivo. The novel nanosystem exhibited enhanced tumor killing efficacy and improved safety compared with traditional PDT and ferroptosis therapy.